{
    "table_title": "Table 1 Demographics and baseline characteristics of the participants",
    "source": "Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trial",
    "columns": [
        "Characteristics",
        "FDC of MSP (N=118)",
        "MS (N=118)",
        "P value"
    ],
    "data": [
        {
            "Characteristics": "Male, n (%)",
            "FDC of MSP (N=118)": "62 (52.5%)",
            "MS (N=118)": "63 (53.4%)",
            "P value": "0.43"
        },
        {
            "Characteristics": "Female, n (%)",
            "FDC of MSP (N=118)": "56 (47.5%)",
            "MS (N=118)": "55 (46.6%)",
            "P value": "0.37"
        },
        {
            "Characteristics": "Age, years, mean (SD)",
            "FDC of MSP (N=118)": "51.7 (8.01)",
            "MS (N=118)": "49.6 (9.54)",
            "P value": "0.0787"
        },
        {
            "Characteristics": "Weight, kg, mean (SD)",
            "FDC of MSP (N=118)": "67.1 (12.87)",
            "MS (N=118)": "65.5 (10.94)",
            "P value": "0.3074"
        },
        {
            "Characteristics": "Height, cm, mean (SD)",
            "FDC of MSP (N=118)": "162.8 (8.23)",
            "MS (N=118)": "161.5 (7.79)",
            "P value": "0.2081"
        },
        {
            "Characteristics": "BMI, kg/m², mean (SD)",
            "FDC of MSP (N=118)": "25.2 (3.81)",
            "MS (N=118)": "25.1 (3.55)",
            "P value": "0.772"
        },
        {
            "Characteristics": "Waist circumference, inches, mean (SD)",
            "FDC of MSP (N=118)": "36.8 (3.62)",
            "MS (N=118)": "36.2 (3.68)",
            "P value": "0.2106"
        },
        {
            "Characteristics": "Waist-to-hip ratio, mean (SD)",
            "FDC of MSP (N=118)": "0.9 (0.07)",
            "MS (N=118)": "0.9 (0.10)",
            "P value": "0.3733"
        },
        {
            "Characteristics": "HbA1C, %, mean (SD)",
            "FDC of MSP (N=118)": "9.21 (0.78)",
            "MS (N=118)": "9.25 (0.78)",
            "P value": "0.7181"
        },
        {
            "Characteristics": "Duration of diabetes, months, mean (SD), range",
            "FDC of MSP (N=118)": "41.1 (33.47), 2–169.4",
            "MS (N=118)": "36.5 (42.86), 1.5–360.6",
            "P value": "0.3524"
        }
    ],
    "footnote": "FDC of MSP = fixed-dose combination of metformin, sitagliptin, and pioglitazone; MS = FDC of metformin and sitagliptin; SD = standard deviation"
}